Valued at $131.7M at its later-stage round, Dec 2025. Nothing has traded since.
- ·Watch Imbria Pharmaceuticals: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Imbria Pharmaceuticals funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Later Stage VC (Series B) | $66.7M | ▮ | ▮ |
| Jun 2020 | Early Stage VC | $40.7M | ▮ | ▮ |
Membership and data by Private Market View
Imbria Pharmaceuticals valuation
Imbria Pharmaceuticals was valued at $132 million at its later-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Imbria Pharmaceuticals raised?
Imbria Pharmaceuticals has raised $152 million in total; 2 of its rounds are on record. The largest on record was a $66.7 million Series B in Dec 2025.
Imbria Pharmaceuticals has filed 2 Form Ds with the SEC since 2020, most recently in Apr 2025 ($59.2 million sold to 8 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Alchemab Therapeutics ($138 million), Tahoe ($131 million) and Vivace Therapeutics ($125 million).
How Imbria Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Imbria Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Imbria Pharmaceuticals
- What is Imbria Pharmaceuticals worth?
- Imbria Pharmaceuticals is valued at $131.7M as of Oct 2026. Valued at $131.7M at its later-stage round, Dec 2025. Nothing has traded since.
- How much has Imbria Pharmaceuticals raised?
- Imbria Pharmaceuticals has raised $151.9M in total funding across 2 recorded rounds.
- When did Imbria Pharmaceuticals last raise?
- Imbria Pharmaceuticals last raised in Dec 2025 (Later Stage VC (Series B)), raising $66.7M.